
51 - 200 employees
Founded 2016
💰 $205M Post-IPO Equity on 2022-06
Scholar Rock is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Our most advanced investigational product candidate, apitegromab (SRK-015), a
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🕒 Yesterday
51 - 200
Patient access coordinator supporting SMA therapy patients for Scholar Rock’s rare neuromuscular disease treatments. Coordinating education, reimbursement, therapy access, and continuity of care.
🏰 Missouri – Remote
💵 $175k - $220k / year
💰 $205M Post-IPO Equity on 2022-06
⏰ Full Time
🟡 Mid-level
🟠 Senior
👻 Ghost score 5%
🕒 Yesterday
51 - 200
Neuromuscular Account Manager advancing Scholar Rock’s SMA treatment through healthcare-provider engagement. Building territory strategies, educating clinicians, and coordinating access across rare-disease stakeholders.
🗽 New York – Remote
💵 $205k - $240k / year
💰 $205M Post-IPO Equity on 2022-06
⏰ Full Time
🟠 Senior
🔴 Lead
💰 Account Manager
👻 Ghost score 5%
🕒 September 29
51 - 200
Director of Market Insights shaping market intelligence and launch strategy for Scholar Rock, a biopharmaceutical company developing treatments for rare neuromuscular diseases.
🍂 Massachusetts – Remote
💰 $205M Post-IPO Equity on 2022-06
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 15%
🕒 July 28
51 - 200
Associate Director/Director of Patient Marketing for apitegromab at a biopharmaceutical company. Focus on developing patient engagement strategies and executing promotional tactics.
🍂 Massachusetts – Remote
💰 $205M Post-IPO Equity on 2022-06
⏰ Full Time
🟠 Senior
🎡 Marketing
👻 Ghost score 20%